Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The G-CSF (Granulocyte Colony Stimulating Factors) market is forecasted to achieve high growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 4%, as per The Business Research Company’s market report!

Read More On The G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2022 – https://www.thebusinessresearchcompany.com/report/G-CSF -global-market-report

The G-CSF (Granulocyte Colony Stimulating Factors) Market Size In 2022 And Forecast
The global G-CSF (Granulocyte Colony Stimulating Factors) market is expected to grow from $7.37 billion in 2021 to $7.99 billion in 2022 at a compound annual growth rate (CAGR) of 8.5%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The G-CSF market is expected to reach $9.48 billion in 2026 at a CAGR of 4.4%.

The G-CSF (Granulocyte Colony Stimulating Factors) market consists of sales of G-CSF drugs and relates services.

Request for A Free Sample Of The Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3466&type=smp

Increase In Prevalence Of Cancer Is Driving The Growth Of The G-CSF (Granulocyte Colony Stimulating Factors) Market
According to the International Agency for Research on Cancer (IARC), by 2040, the global burden is projected to increase to 27.5 million active cancer incidents and 16.3 million cancer deaths primarily due to population growth and ageing. About 70% of deaths from cancer occur in low- and middle-income countries. G-CSF is a class of growth factor which produces white blood cells in the bone marrow to minimize the risk of infection and sepsis. In cancer patients, G-CSF accelerates recovery and reduces mortality from neutropenia after chemotherapy for cancer. It can also reduce infection after certain forms of treatment for cancer. Therefore, the increasing prevalence of cancer is expected to drive the growth of the G-CSF market.

Competitive Landscape And The Regional Analysis Of The G-CSF (Granulocyte Colony Stimulating Factors) Market
Major players in the G-CSF (Granulocyte Colony Stimulating Factors) market are BioCad, Teva Pharmaceuticals, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Dong-A Socio Group, Amgen, Dr. Reddy’s Laboratories and Celltrion Inc.

The G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the G-CSF (Granulocyte Colony Stimulating Factors) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the G-CSF (Granulocyte Colony Stimulating Factors) market.

G-CSF (Granulocyte Colony Stimulating Factors) Market Segmentation By The Business Research Company

1) By Type: Lenograstim (Granocyte), Filgrastim (Neupogen, Zarzio, Nivestim, Accofil), Long Acting (Pegylated) Filgrastim (Pegfilgrastim, Neulasta, Pelmeg, Ziextenco), Lipegfilgrastim (Lonquex)

2) By Application: Oncological Diseases, Blood Disorders, Growth Hormone Deficiencies, Chronic and Autoimmune Disorders, Others

3) By Product: Tablet, Capsule, Others

Here Are Some Reports Related To The G-CSF (Granulocyte Colony Stimulating Factors) Market –

Oncology Molecular Diagnostics Global Market Report 2022

Antisense & RNAi Therapeutics Global Market Report 2022

Biosimilar Monoclonal Antibodies Global Market Report 2022

Get In Touch With Us – Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Check out our:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model